Optimal treatment strategy of mineralocorticoid receptor antagonists for primary aldosteronism
Not Applicable
- Conditions
- Primary aldosteronism
- Registration Number
- JPRN-UMIN000030932
- Lead Sponsor
- Osaka University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who did not agree to this study, receiving sex hormone therapy, having heart diseases (NYHA 3 degree or higher), liver dysfunction (AST/ALT over 100IU/mL or T-Bil over 2.0mg/dL), renal dysfunction (Cr over 2.0mg/dL), serious diseases such as malignant diseases and judged inappropriate.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood pressure Urinary albumin
- Secondary Outcome Measures
Name Time Method QOL eGFR